Intercept Announces Development Program for Next-Generation

Intercept Announces Development Program for Next-Generation FXR Agonist INT-787 in Severe Alcohol-Associated Hepatitis

Intercept Announces Development Program for Next-Generation FXR Agonist INT-787 in Severe Alcohol-Associated Hepatitis
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , France , Washington , United States , Nareg Sagherian , M Michelle Berrey , Karen Preble , Linkedin , Global Corporate Communications , Company On Twitter , Intercept Pharmaceuticals Inc , Research Development , Nasdaq , Liver Meeting , Intercept Pharmaceuticals , American Association , Liver Diseases , Severe Alcohol Associated Hepatitis , Chief Medical Officer , Executive Director , Global Investor , Global Corporate ,